STOCK TITAN

IDEXX Laboratories to Release 2022 First Quarter Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

IDEXX Laboratories, Inc. (NASDAQ: IDXX) has announced the release of its 2022 first quarter financial results, scheduled for May 4, 2022, before market opening. An analyst conference call will follow at 8:30 a.m. ET, accessible via a live webcast on the IDEXX website. The archived webcast will be available after 1:00 p.m. ET and will remain for one year. IDEXX, a leader in veterinary diagnostics and healthcare innovation, employs over 10,000 people and serves customers in over 175 countries worldwide.

Positive
  • Scheduled release of Q1 results demonstrates transparency.
  • Conference call provides investors with timely updates.
  • IDEXX's global presence indicates market strength.
Negative
  • None.

WESTBROOK, Maine, April 11, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2022 first quarter results for Wednesday, May 4, 2022 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Individuals can access a live webcast of the conference call through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year.

The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-866-374-5140 or 1-404-400-0571 and reference pin 35572192. 

IDEXX Laboratories, Inc. logo. (PRNewsFoto/IDEXX Laboratories, Inc.)

About IDEXX Laboratories
IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, offering diagnostic and software products and services that deliver solutions and insights to practicing veterinarians around the world. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful and effective practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk and point-of-care and laboratory diagnostics for human medicine. Headquartered in Maine, IDEXX employs over 10,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com.

Contact:
Investor Relations:
investorrelations@idexx.com
207-556-8155

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/idexx-laboratories-to-release-2022-first-quarter-financial-results-301523085.html

SOURCE IDEXX Laboratories, Inc.

FAQ

When will IDEXX release its Q1 2022 financial results?

IDEXX will release its Q1 2022 financial results on May 4, 2022.

What time is the IDEXX analyst conference call?

The analyst conference call will begin at 8:30 a.m. ET on May 4, 2022.

How can I access the IDEXX conference call?

The IDEXX conference call can be accessed via a live webcast on their investor relations website.

Will the IDEXX conference call be available for later viewing?

Yes, an archived edition of the conference call will be available after 1:00 p.m. ET on May 4, 2022, for one year.

What is IDEXX's role in veterinary diagnostics?

IDEXX is a leader in veterinary diagnostics, providing innovative products and services to veterinarians worldwide.

Idexx Laboratories Inc

NASDAQ:IDXX

IDXX Rankings

IDXX Latest News

IDXX Stock Data

33.64B
81.89M
0.94%
96.37%
2.79%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States of America
WESTBROOK